CLEC9A and cancer: Clec9a is a potential cancer vaccine target that is expressed on a small subset of DCs, which have important immune functions including phagocytosis, oxidative burst, regulation of transcription, cytokine production, cytotoxicity, and antigen cross-presentation 32, 39, 40.